Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
Zebrafish models relevant to studying central opioid and endocannabinoid systems. / Demin, Konstantin A.; Meshalkina, Darya A.; Kysil, Elana V. и др.
в: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Том 86, 30.08.2018, стр. 301-312.Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
}
TY - JOUR
T1 - Zebrafish models relevant to studying central opioid and endocannabinoid systems
AU - Demin, Konstantin A.
AU - Meshalkina, Darya A.
AU - Kysil, Elana V.
AU - Antonova, Kristina A.
AU - Volgin, Andrey D.
AU - Yakovlev, Oleg A.
AU - Alekseeva, Polina A.
AU - Firuleva, Maria M.
AU - Lakstygal, Anton M.
AU - de Abreu, Murilo S.
AU - Barcellos, Leonardo J.G.
AU - Bao, Wandong
AU - Friend, Ashton J.
AU - Amstislavskaya, Tamara G.
AU - Rosemberg, Denis B.
AU - Musienko, Pavel E.
AU - Song, Cai
AU - Kalueff, Allan V.
N1 - Publisher Copyright: © 2018 Elsevier Inc.
PY - 2018/8/30
Y1 - 2018/8/30
N2 - The endocannabinoid and opioid systems are two interplaying neurotransmitter systems that modulate drug abuse, anxiety, pain, cognition, neurogenesis and immune activity. Although they are involved in such critical functions, our understanding of endocannabinoid and opioid physiology remains limited, necessitating further studies, novel models and new model organisms in this field. Zebrafish (Danio rerio) is rapidly emerging as one of the most effective translational models in neuroscience and biological psychiatry. Due to their high physiological and genetic homology to humans, zebrafish may be effectively used to study the endocannabinoid and opioid systems. Here, we discuss current models used to target the endocannabinoid and opioid systems in zebrafish, and their potential use in future translational research and high-throughput drug screening. Emphasizing the high degree of conservation of the endocannabinoid and opioid systems in zebrafish and mammals, we suggest zebrafish as an excellent model organism to study these systems and to search for the new drugs and therapies targeting their evolutionarily conserved mechanisms.
AB - The endocannabinoid and opioid systems are two interplaying neurotransmitter systems that modulate drug abuse, anxiety, pain, cognition, neurogenesis and immune activity. Although they are involved in such critical functions, our understanding of endocannabinoid and opioid physiology remains limited, necessitating further studies, novel models and new model organisms in this field. Zebrafish (Danio rerio) is rapidly emerging as one of the most effective translational models in neuroscience and biological psychiatry. Due to their high physiological and genetic homology to humans, zebrafish may be effectively used to study the endocannabinoid and opioid systems. Here, we discuss current models used to target the endocannabinoid and opioid systems in zebrafish, and their potential use in future translational research and high-throughput drug screening. Emphasizing the high degree of conservation of the endocannabinoid and opioid systems in zebrafish and mammals, we suggest zebrafish as an excellent model organism to study these systems and to search for the new drugs and therapies targeting their evolutionarily conserved mechanisms.
KW - Endocannabinoid system
KW - High-throughput screening
KW - Opioid system
KW - Zebrafish
KW - HYDROLASE INHIBITOR URB597
KW - CONDITIONED PLACE PREFERENCE
KW - ADULT ZEBRAFISH
KW - ANXIETY-LIKE BEHAVIOR
KW - RAT MODEL
KW - PHYLOGENETIC DISTRIBUTION
KW - CANNABINOID CB1 RECEPTOR
KW - BINDING-SITES
KW - SALVINORIN-A
KW - MOLECULAR-MECHANISMS
KW - Zebrafish/metabolism
KW - Central Nervous System/drug effects
KW - Receptors, Opioid/metabolism
KW - Animals
KW - Models, Animal
KW - Endocannabinoids/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85047070946&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2018.03.024
DO - 10.1016/j.pnpbp.2018.03.024
M3 - Review article
C2 - 29604314
AN - SCOPUS:85047070946
VL - 86
SP - 301
EP - 312
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
SN - 0278-5846
ER -
ID: 13488830